These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 23313601)

  • 1. Structure elucidation and identification of a common metabolite for naphthoylindole-based synthetic cannabinoids using LC-TOF and comparison to a synthetic reference standard.
    Lovett DP; Yanes EG; Herbelin TW; Knoerzer TA; Levisky JA
    Forensic Sci Int; 2013 Mar; 226(1-3):81-7. PubMed ID: 23313601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of new classes of recreational drugs in sewage: synthetic cannabinoids and amphetamine-like substances.
    Reid MJ; Derry L; Thomas KV
    Drug Test Anal; 2014; 6(1-2):72-9. PubMed ID: 23460377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine specimens.
    Wohlfarth A; Scheidweiler KB; Castaneto M; Gandhi AS; Desrosiers NA; Klette KL; Martin TM; Huestis MA
    Clin Chem Lab Med; 2015 Feb; 53(3):423-34. PubMed ID: 25263309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of an on-site drug-testing device for the detection of synthetic cannabinoids in illegal herbal products].
    Uchiyama N; Kikura-Hanajiri R; Hakamatsuka T
    Yakugaku Zasshi; 2015; 135(3):535-41. PubMed ID: 25759062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of urinary metabolites of JWH-018 and JWH-073 in legal cases.
    Jang M; Yang W; Choi H; Chang H; Lee S; Kim E; Chung H
    Forensic Sci Int; 2013 Sep; 231(1-3):13-9. PubMed ID: 23890611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a mass spectrometric hydroxyl-position determination method for the hydroxyindole metabolites of JWH-018 by GC-MS/MS.
    Kusano M; Zaitsu K; Yamanaka M; Hisatsune K; Asano T; Taki K; Hayashi Y; Tsuchihashi H; Ishii A
    J Mass Spectrom; 2016 May; 51(5):350-7. PubMed ID: 27194519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the major urinary metabolites in man of seven synthetic cannabinoids of the aminoalkylindole type present as adulterants in 'herbal mixtures' using LC-MS/MS techniques.
    Hutter M; Broecker S; Kneisel S; Auwärter V
    J Mass Spectrom; 2012 Jan; 47(1):54-65. PubMed ID: 22282090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical analysis of synthetic cannabinoids as designer drugs in herbal products.
    Uchiyama N; Kikura-Hanajiri R; Ogata J; Goda Y
    Forensic Sci Int; 2010 May; 198(1-3):31-8. PubMed ID: 20117892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolism.
    Hutter M; Moosmann B; Kneisel S; Auwärter V
    J Mass Spectrom; 2013 Jul; 48(7):885-94. PubMed ID: 23832945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and structural elucidation of four cannabimimetic compounds (RCS-4, AM-2201, JWH-203 and JWH-210) in seized products.
    Denooz R; Vanheugen JC; Frederich M; de Tullio P; Charlier C
    J Anal Toxicol; 2013 Mar; 37(2):56-63. PubMed ID: 23339188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of 30 synthetic cannabinoids in serum by liquid chromatography-electrospray ionization tandem mass spectrometry after liquid-liquid extraction.
    Kneisel S; Auwärter V
    J Mass Spectrom; 2012 Jul; 47(7):825-35. PubMed ID: 22791249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct screening of herbal blends for new synthetic cannabinoids by MALDI-TOF MS.
    Gottardo R; Chiarini A; Dal Prà I; Seri C; Rimondo C; Serpelloni G; Armato U; Tagliaro F
    J Mass Spectrom; 2012 Jan; 47(1):141-6. PubMed ID: 22282100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of 22 synthetic cannabinoids in human hair by liquid chromatography-tandem mass spectrometry.
    Hutter M; Kneisel S; Auwärter V; Neukamm MA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug; 903():95-101. PubMed ID: 22835826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput bioanalytical method for analysis of synthetic cannabinoid metabolites in urine using salting-out sample preparation and LC-MS/MS.
    Yanes EG; Lovett DP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 909():42-50. PubMed ID: 23153643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
    Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
    Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Separation and structural characterization of the synthetic cannabinoids JWH-412 and 1-[(5-fluoropentyl)-1H-indol-3yl]-(4-methylnaphthalen-1-yl)methanone using GC-MS, NMR analysis and a flash chromatography system.
    Moosmann B; Kneisel S; Girreser U; Brecht V; Westphal F; Auwärter V
    Forensic Sci Int; 2012 Jul; 220(1-3):e17-22. PubMed ID: 22264627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of synthetic cannabinoids in U.S. athletes: initial findings.
    Heltsley R; Shelby MK; Crouch DJ; Black DL; Robert TA; Marshall L; Bender CL; DePriest AZ; Colello MA
    J Anal Toxicol; 2012 Oct; 36(8):588-93. PubMed ID: 22872465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic cannabinoids in "spice-like" herbal blends: first appearance of JWH-307 and recurrence of JWH-018 on the German market.
    Ernst L; Krüger K; Lindigkeit R; Schiebel HM; Beuerle T
    Forensic Sci Int; 2012 Oct; 222(1-3):216-22. PubMed ID: 22748479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker discovery in biological specimens (plasma, hair, liver and kidney) of diabetic mice based upon metabolite profiling using ultra-performance liquid chromatography with electrospray ionization time-of-flight mass spectrometry.
    Tsutsui H; Maeda T; Min JZ; Inagaki S; Higashi T; Kagawa Y; Toyo'oka T
    Clin Chim Acta; 2011 May; 412(11-12):861-72. PubMed ID: 21185819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation and identification of the human N+-glucuronide metabolite of cediranib.
    Lenz EM; Spear M; Drake C; Pollard CR; Ward M; Schulz-Utermoehl T; Harrison M
    J Pharm Biomed Anal; 2010 Nov; 53(3):526-36. PubMed ID: 20409669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.